No association between HLA-B and cutaneous reactions to sulphonamides in human immunodeficiency virus-infected patients.
Z G
ZG
Vitezica
P
P
Wolkenstein
C
C
Lonjou
M
M
Eliaszewicz
X
X
Sicard
J-C
JC
Roujeau
A
A
Hovnanian
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000235:genetics*; D005260:Female; D020022:Genetic Predisposition to Disease; D015235:HLA-B Antigens / Q000235:genetics*; D006801:Humans; D008297:Male; D011446:Prospective Studies; D013449:Sulfonamides / Q000009:adverse effects*
D000900:Anti-Bacterial Agents; D015235:HLA-B Antigens; D013449:Sulfonamides